Yüklüyor......
Panitumumab in Metastatic Colorectal Cancer: The Importance of Tumour RAS Status
Tumour biomarker status is being used more and more frequently to guide treatment decisions in patients with metastatic colorectal cancer (mCRC). Continued cycles of hypothesis generation and biomarker testing in retrospective, prospective–retrospective and prospective analyses from studies of the e...
Kaydedildi:
| Yayımlandı: | Drugs |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer International Publishing
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4419154/ https://ncbi.nlm.nih.gov/pubmed/25895463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-015-0386-x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|